Molecular Data Inc
NASDAQ:MKD
Molecular Data Inc
Cash from Operating Activities
Molecular Data Inc
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
M
|
Molecular Data Inc
NASDAQ:MKD
|
Cash from Operating Activities
-¥234.1m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Cash from Operating Activities
¥190.7B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
5%
|
CAGR 10-Years
22%
|
|
Pinduoduo Inc
NASDAQ:PDD
|
Cash from Operating Activities
¥94.2B
|
CAGR 3-Years
49%
|
CAGR 5-Years
65%
|
CAGR 10-Years
N/A
|
|
JD Health International Inc
HKEX:6618
|
Cash from Operating Activities
¥5.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
161%
|
CAGR 10-Years
N/A
|
|
Meituan
HKEX:3690
|
Cash from Operating Activities
¥40.5B
|
CAGR 3-Years
68%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
JD.Com Inc
HKEX:9618
|
Cash from Operating Activities
¥59.5B
|
CAGR 3-Years
12%
|
CAGR 5-Years
23%
|
CAGR 10-Years
32%
|
See Also
What is Molecular Data Inc's Cash from Operating Activities?
Cash from Operating Activities
-234.1m
CNY
Based on the financial report for Dec 31, 2020, Molecular Data Inc's Cash from Operating Activities amounts to -234.1m CNY.
What is Molecular Data Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 3Y
-8%
Over the last year, the Cash from Operating Activities growth was -144%. The average annual Cash from Operating Activities growth rates for Molecular Data Inc have been -8% over the past three years .